Telix Pharmaceuticals

Telix Pharmaceuticals is a clinical-stage biopharamaceutical company.

Telix Pharmaceuticals Limited (“Telix”) is a clinical-stage biopharamaceutical company headquartered in Melbourne, Australia. Telix is developing an advanced portfolio of clinical-stage products that address significant unmet medical need in oncology, particularly renal, prostate and brain (glioblastoma) cancer. Telix’s pipeline consists of “theranostic” radiopharmaceuticals, agents that can be used both diagnostically (via PET imaging) and therapeutically to patient benefit. Telix is an unlisted public company.